Literature DB >> 13563621

Trypsin inhibitors of human serum. I. Standardization, mechanism of reaction, and normal values.

H F BUNDY, J W MEHL.   

Abstract

Entities:  

Keywords:  TRYPSIN/antagonists

Mesh：

Substances：

Year:  1958        PMID： 13563621      PMCID： PMC1062754          DOI： 10.1172/JCI103689

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  13 in total

1.  Reversible association processes of globular proteins. VI. The combination of trypsin with soybean inhibitor.

Authors:  R F STEINER
Journal:  Arch Biochem Biophys       Date:  1954-03       Impact factor: 4.013

2.  Determination of trypsin inhibitor in blood plasma.

Authors:  S F McCANN; M LASKOWSKI
Journal:  J Biol Chem       Date:  1953-09       Impact factor: 5.157

3.  METHODS FOR MEASURING THE ACTIVITY OF COMPONENTS OF THE STREPTOCOCCAL FIBRINOLYTIC SYSTEM, AND STREPTOCOCCAL DESOXYRIBONUCLEASE.

Authors:  L R Christensen
Journal:  J Clin Invest       Date:  1949-01       Impact factor: 14.808

4.  Competition among trypsin inhibitors.

Authors:  N M GREEN
Journal:  J Biol Chem       Date:  1953-12       Impact factor: 5.157

5.  Studies of various tests for malignant neoplastic diseases. VII. Serum inhibitors of chymotrypsin and trypsin.

Authors:  A C PEACOCK; J J SHEEHY
Journal:  J Natl Cancer Inst       Date:  1952-02       Impact factor: 13.506

6.  On the mechanism of enzyme acition. XLVI. The effect of certain ions on crystalline trypsin and reinvestigation of its isoelectric point.

Authors:  M BIER; F F NORD
Journal:  Arch Biochem Biophys       Date:  1951-09       Impact factor: 4.013

7.  [Calcium role in trypsin-serum albumin system].

Authors:  L GORINI
Journal:  Biochim Biophys Acta       Date:  1951-07

8.  Some observations on a trypsin trypsin-inhibitor system.

Authors:  A D McLAREN
Journal:  C R Trav Lab Carlsberg Chim       Date:  1952

9.  Studies on the inhibition of proteolytic enzymes by serum. II. Demonstration that separate proteolytic inhibitors exist in serum; their distinctive properties and the specificity of their action.

Authors:  N R SHULMAN
Journal:  J Exp Med       Date:  1952-06       Impact factor: 14.307

10.  Studies on the inhibition of proteolytic enzymes by serum. I. The mechanism of the inhibition of trypsin, plasmin, and chymotrypsin by serum using fibrin tagged with I131 as a substrate.

Authors:  N R SHULMAN
Journal:  J Exp Med       Date:  1952-06       Impact factor: 14.307
View more
  9 in total

1.  [On trypsin inhibitor activity of amniotic fluid].

Authors:  H J WORASCHK; M KRESSER
Journal:  Arch Gynakol       Date:  1962

2.  The further purification and characterization of mouse bone collagenase.

Authors:  S Sakamoto; P Goldhaber; M J Glimcher
Journal:  Calcif Tissue Res       Date:  1972

3.  Further studies on the nature of the components in serum which inhibit mouse bone collagenase.

Authors:  S Sakamoto; P Goldhaber; M J Glimcher
Journal:  Calcif Tissue Res       Date:  1972

4.  An investigation of the role of intraluminal proteolytic enzymes and intracellular enzyme inhibitors in ulcerative colitis.

Authors:  D M Goldberg; R Campbell; A D Roy
Journal:  Br J Exp Pathol       Date:  1972-08

5.  The role of trypsin in the pre-treatment of chromosomes for Giemsa banding.

Authors:  B R Korf; B E Schuh; M J Salwen; D Warburton; O J Miller
Journal:  Hum Genet       Date:  1976-01-28       Impact factor: 4.132

6.  The proteolytic effect of pancreatic pseudocyst fluid on vessel walls.

Authors:  A Lasson; K Jönsson; I Lore'n; N H Sternby
Journal:  Int J Pancreatol       Date:  1994-08

7.  Failure of trasylol to reduce intestinal content of trypsin and chymotrypsin in man.

Authors:  D M Goldberg; R Campbell; A D Roy
Journal:  Gut       Date:  1970-08       Impact factor: 23.059

8.  Proteolytic activity in pancreatic pseudocyst fluid.

Authors:  A Lasson; S Genell; A Nilsson
Journal:  Int J Pancreatol       Date:  1994-06

9.  Trypsin potentiates human fibrocyte differentiation.

Authors:  Michael J V White; Melissa Glenn; Richard H Gomer
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.